Search results for: Pricing and Reimbursement
Filter search results
OHE Models Incentives for Antibiotic Drug Development
18 March 2014
The OHE model takes into account the value to society of new antibiotics as well as the risks and rewards for payers and the entities developing the new drugs. A…
Spotlight on OHE: NICE, Biosimilars, HTA
17 June 2014
…that are part of the value based assessment consultation. She illustrated how two suggested decision-making factors, burden of illness and wider societal impact, might be measured and calculated for specific…
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
…publicly available sources and an online survey. The countries included are Australia, Canada, Denmark, France, Italy, Korea, The Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia-Herzegovina, Ecuador, Egypt and Ghana. (PHP86,…
OHE at ISPOR Europe: Posters
13 November 2014
…Sussex, Dyfrig Hughes (Bangor University) and Nancy Devlin Ispor are uk_systems_innovation_compatible_ac from Office of Health Economics Amanda Chapman, C. A. Taylor (University of Birmingham) and A. J. Girling (University…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
…scenarios involving hypothetical patients and medical conditions. In order to minimise bias, researchers usually present the scenarios in an abstract manner and provide limited descriptive information. This has led to…
Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations
25 August 2015
…does not account for drug life cycle pricing, i.e. the evolution of a drug price throughout its life. In reality, the drug launch price (which is considered in cost-effectiveness analyses)…
Eliciting the Relative Value of Life Extension at the End of Life
29 November 2016
…OHE’s Koonal Shah provided a critique and discussion. Koonal set out the strengths and limitations of the Q methodology approach, and described how Rachel’s study fits within the existing empirical…
The Office of Health Economics Becomes a Registered Charity
3 February 2017
…to serve the public interest by providing research and analysis that will increase understanding of health, health care and biomedical research issues and public policy challenges. OHE’s new status as…
Is There Societal Support for an End of Life Premium?
8 May 2017
…to address some of the limitations and ambiguities in the earlier research on this topic. Koonal highlighted three innovative studies led by researchers in the Netherlands, Denmark and Scotland. The…